Cargando…
Neuregulin-1 attenuates mortality associated with experimental cerebral malaria
BACKGROUND: Cerebral Malaria (CM) is a diffuse encephalopathy caused by Plasmodium falciparum infection. Despite availability of antimalarial drugs, CM-associated mortality remains high at approximately 30% and a subset of survivors develop neurological and cognitive disabilities. While antimalarial...
Autores principales: | Solomon, Wesley, Wilson, Nana O, Anderson, Leonard, Pitts, Sidney, Patrickson, John, Liu, Mingli, Ford, Byron D, Stiles, Jonathan K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3906904/ https://www.ncbi.nlm.nih.gov/pubmed/24433482 http://dx.doi.org/10.1186/1742-2094-11-9 |
Ejemplares similares
-
Neuregulin-1 attenuates experimental cerebral malaria (ECM) pathogenesis by regulating ErbB4/AKT/STAT3 signaling
por: Liu, Mingli, et al.
Publicado: (2018) -
Pharmacologic Inhibition of CXCL10 in Combination with Anti-malarial Therapy Eliminates Mortality Associated with Murine Model of Cerebral Malaria
por: Wilson, Nana O., et al.
Publicado: (2013) -
Heme Mediated STAT3 Activation in Severe Malaria
por: Liu, Mingli, et al.
Publicado: (2012) -
Modelling heme-mediated brain injury associated with cerebral malaria in human brain cortical organoids
por: Harbuzariu, Adriana, et al.
Publicado: (2019) -
CXCL10 Gene Promoter Polymorphism -1447A>G Correlates with Plasma CXCL10 Levels and is Associated with Male Susceptibility to Cerebral Malaria
por: Wilson, Nana, et al.
Publicado: (2013)